<DOC>
	<DOCNO>NCT02445794</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics RT001 patient Friedreich 's ataxia .</brief_summary>
	<brief_title>A First Human Study RT001 Patients With Friedreich 's Ataxia</brief_title>
	<detailed_description>Study RT001-002 randomize , double-blind , control , ascend dose study evaluate safety , tolerability , pharmacokinetic , disease state , exploratory endpoint patient Friedreich 's ataxia oral administration . The study include 2 dose level RT001 .</detailed_description>
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<criteria>1 . Male female 18 50 year age 2 . Medical history consistent symptom FRDA ≤ 25 year age 3 . Homozygous GAA repeat expansion Frataxin gene affect range FRDA 4 . FARSNeurological score 2090 point 5 . Ambulatory ( without assistive device ) capable perform assessments/evaluations 6 . Body Mass Index ≤ 29.9 kg/m2 7 . Agrees dietary restriction agree receive call dietary coach 8 . Signed informed consent form prior entry study 9 . Agrees spend required number overnight clinic day 10 . Able provide necessary repeat blood sample 1 . Received treatment experimental therapy within last 30 day prior first dose 2 . Known point mutation FXN gene 3 . History malignancy ( basal cell carcinoma ) 4 . Impaired renal function screen 5 . Alanine transaminase ( ALT ) aspartate transaminase ( AST ) laboratory value &gt; 2 x upper limit normal ( ULN ) screen 6 . Known hepatitis B surface antigen ( HBsAg ) positive , know suspect active hepatitis C infection , know human immunodeficiency virus ( HIV ) positive 7 . Female breastfeed positive pregnancy test 8 . Male participant female participant child bear potential , sexually active unwilling/unable use medically acceptable effective double barrier birth control method throughout study 9 . Unwilling unable comply requirement protocol 10 . Clinically significant cardiac abnormality screen , opinion Investigator , would make patient unsuitable enrollment 11 . Diabetes mellitus ( Type 1 2 ) 12 . Suicidal ideation determine ColumbiaSuicide Severity Rating Scale 13 . History , within last 2 year , alcohol abuse , significant mental illness , physical opioid dependence 14 . Can adhere dietary guidance require follow protocol 15 . Can take medication due impairment swallowing capsule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>